Concepedia

Carrie-Lynn Langlais Furr

CL

Statistics

Publications

5

Citations

587

H-Index

5

Active since

2018

Affiliations

AmpliPhi Biosciences (United States)(Current)

University of California San Diego

Naval Medical Research Command

University of Pennsylvania

University of California System

Carrie-Lynn Langlais Furr is an author at AmpliPhi Biosciences (United States) specializing in bacteriology, microbiology, and medical microbiology.

Publications per year

2018–2019

5

Publications

5

Early clinical experience of bacteriophage therapy in 3 lung transplant recipients

Saima Aslam, Andrew Courtwright, Christine Koval et al. · American Journal of Transplantation · 2019 · 283 citations · Full text

, , +16

Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient

Nancy Law, Cathy Logan, Gordon Yung et al. · Infection · 2019 · 262 citations

, , +15

Bacteriophage Treatment in a Lung Transplant Recipient

Saima Aslam, Gordon Yung, Jennifer M. Dan et al. · The Journal of Heart and Lung Transplantation · 2018 · 20 citations

, , +14

P084 Bacteriophage treatment of multidrug-resistant Pseudomonas aeruginosa pneumonia in a cystic fibrosis patient

Carrie-Lynn Langlais Furr, Susan M. Lehman, Sandra Morales et al. · Journal of Cystic Fibrosis · 2018 · 11 citations · Full text

, , +16

Safety and Efficacy of Bacteriophage Therapy in Lung Transplant Candidates and Recipients

Andrew Courtwright, Christine Koval, Susan M. Lehman et al. · The Journal of Heart and Lung Transplantation · 2019 · 11 citations

, , +14

1–5 of 5